Affinity Asset Advisors’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-74,639
| Closed | -$1.94M | – | 85 |
|
|
2023
Q2 | $1.94M | Hold |
74,639
| – | – | 0.68% | 33 |
|
|
2023
Q1 | $1.55M | Hold |
74,639
| – | – | 0.51% | 40 |
|
|
2022
Q4 | $1.52M | Hold |
74,639
| – | – | 0.6% | 35 |
|
|
2022
Q3 | $2.06M | Buy |
74,639
+5,934
| +9% | +$164K | 0.58% | 32 |
|
|
2022
Q2 | $1.81M | Hold |
68,705
| – | – | 0.76% | 23 |
|
|
2022
Q1 | $5.5M | Buy |
68,705
+11,937
| +21% | +$955K | 0.88% | 18 |
|
|
2021
Q4 | $11.6M | Buy |
56,768
+6,518
| +13% | +$1.33M | 4.2% | 3 |
|
|
2021
Q3 | $16.3M | Buy |
50,250
+8,334
| +20% | +$2.7M | 4.1% | 2 |
|
|
2021
Q2 | $10.9M | Buy |
41,916
+14,765
| +54% | +$3.84M | 3.9% | 3 |
|
|
2021
Q1 | $10.5M | Buy |
27,151
+7,001
| +35% | +$2.7M | 3.56% | 4 |
|
|
2020
Q4 | $8.43M | Buy |
+20,150
| New | +$8.43M | 4.47% | 5 |
|